Semaglutide may protect kidney function in individuals with a pre-existing kidney impairment
The latest analysis from the Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity Trial (SELECT) has...
top of page
Browse by category
Search
SELECT trial: Semaglutide reduces the risk of MACE by 20% in adults with overweight or obesity
Results from the SELECT cardiovascular outcomes trial has revealed that semaglutide 2.4mg demonstrated a statistically significant and...
Browse by tag
bottom of page